Ying Kong

机构：Tianjin Agricultural University, Central South University, Xuzhou Medical College, Heilongjiang University of Chinese Medicine, Beijing Microelectronics Technology Institute, First Affiliated Hospital of Heilongjiang University of Chinese Medicine, Yunnan Institute of Environmental Sciences, Chinese National Engineering Research Center for Control and Treatment of Heavy Metal Pollution, Second Xiangya Hospital of Central South University, First Affiliated Hospital of Zhengzhou University · ORCID：0000-0002-3782-1246

发表论文 37 篇 · 总被引 743 次 · h-index 14

代表论文

• Structure-based discovery of SIAIS001 as an oral bioavailability ALK degrader constructed from Alectinib (2021 · European Journal of Medicinal Chemistry · 被引 45)
• Gut microecology: Why our microbes could be key to our health (2020 · Biomedicine & Pharmacotherapy · 被引 44)
• Discovery of a Brigatinib Degrader SIAIS164018 with Destroying Metastasis-Related Oncoproteins and a Reshuffling Kinome Profile (2021 · Journal of Medicinal Chemistry · 被引 38)
• Myeloid cell‐specific mutation of Spi1 selectively reduces M2 ‐biased macrophage numbers in skeletal muscle, reduces age‐related muscle fibrosis and prevents sarcopenia (2022 · Aging Cell · 被引 25)
• LIPUS regulates the progression of knee osteoarthritis in mice through primary cilia-mediated TRPV4 channels (2024 · APOPTOSIS · 被引 23)
• Isovitexin Depresses Osteoarthritis Progression via the Nrf2/NF-κB Pathway: An in vitro Study (2021 · Journal of Inflammation Research · 被引 18)